Marit Valla
Marit Valla
Førsteamanuensis i patologi
Institutt for klinisk og molekylær medisin Fakultet for medisin og helsevitenskapBakgrunn og aktiviteter
Arbeidsoppgaver
- Førsteamanuensis ved IKOM og overlege ved Avdeling for patologi, St. Olavs hospital
- Forskningen omhandler anvendelse av dyplæringsmetoder (kunstig intelligens) ved brystkreft, molekylpatologiske studier i brystkreft og gynekologisk patologi.
- Veileder PhD-stipendiater og hovedoppgavestudenter på medisinstudiet
- Undervisningsenhetsleder i enheten anatomi, patologi og rettsmedisin
- Underviser medisinstudenter.
Kompetanse og interesseområder
- Spesialist i patologi med spesiell kompetanse innen mammapatologi og gynekologisk patologi.
- Bruk av kunstig intelligens i patologi, molekylærpatologi
- Tverrfaglig arbeid
- Medlem av Forskningsutvalget og styremedlem i den norske patologforening
- Medlem av Nordic Network of Gynecologic Pathologists.
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2022) Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods. Diagnostic Pathology.
- (2021) FGFR1 copy number in breast cancer: associations with proliferation, histopathological grade and molecular subtypes. Journal of Clinical Pathology.
- (2021) ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes. Breast Cancer Research and Treatment.
- (2021) FastPathology: An open-source platform for deep learning-based research and decision support in digital pathology. IEEE Access. vol. 9.
- (2021) The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study. BMC Cancer. vol. 21 (1).
- (2021) DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis. Breast Cancer Research and Treatment. vol. 187 (1).
- (2020) MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes. Breast Cancer Research and Treatment. vol. 180.
- (2018) The prognostic value of androgen receptors in breast cancer subtypes. Breast Cancer Research and Treatment.
- (2018) Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs. Neoplasia. vol. 20 (4).
- (2018) Characterization of FGD5 expression in primary breast cancers and lymph node metastases. Journal of Histochemistry and Cytochemistry.
- (2017) Basal markers and prognosis in luminal breast cancer. Breast Cancer Research and Treatment. vol. 163 (2).
- (2017) A selective biomarker panel increases reproducibility and accuracy in endometrial biopsy diagnosis. International Journal of Gynecological Pathology. vol. 36 (4).
- (2017) FGD5 amplification in breast cancer patients is associated with tumor proliferation and a poorer prognosis. Breast Cancer Research and Treatment. vol. 162 (2).
- (2016) Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia. Acta Obstetricia et Gynecologica Scandinavica. vol. 95 (11).
- (2016) Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Gynecologic Oncology. vol. 143 (3).
- (2016) Molecular subtypes of breast cancer: Long-term incidence trends and prognostic differences. Cancer Epidemiology, Biomarkers and Prevention. vol. 25 (12).
- (2012) Implementation of step sectioning in the examination of sentinel lymph nodes to improve the detection of micrometastases in breast cancer patients. APMIS - Journal of Pathologiy, Microbiology and Immunology. vol. 120 (7).
- (2005) Omorganisering innen kirurgi har følger for nyremedisinsk virksomhet. Tidsskrift for Den norske legeforening. vol. 125.